The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement

Vasilios G. Athyros, Christos S. Mantzoros, Απόστολος Τσάπας et al.|Metabolism|2017

Cited by 251